Kuros Biosciences’ MagnetOs Granules FDA-Cleared for Expanded Spinal Indications

Kuros Biosciences' MagnetOs Granules have been cleared by FDA for expanded indications in the spine, making it the second-ever bone graft to achieve clearance for standalone use in the spine based on human clinical data.

Clearance was attained using radiographic data, clinical outcomes and safety data from 50 patients who were enrolled in a...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us